<DOC>
	<DOC>NCT01035411</DOC>
	<brief_summary>This clinical study will aid future formulation development and optimisation of AZD9668 tablets by evaluating possible effects of minor changes to the formulation and process on the rate and extent of absorption.</brief_summary>
	<brief_title>AZD9668 Relative Bioavailability</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<criteria>Provision of informed consent prior to any studyspecific procedures female subjects may be of nonchild bearing potential (i.e. post menopausal or surgically sterile) or of child bearing potential Body mass index (BMI) ≥18.0 and ≤30.0 kg/m2 calculated from height and weight at the screening visit; minimum weight 50 kg. Clinically normal physical and laboratory findings as judged by the investigator, including negative test results for drugofabuse, alcohol, cotinine and negative test results for Hepatitis B surface antigen, antibodies to Hepatitis C virus and antibodies to HIV1/2 at the screening visit Be a none smoker or exsmoker who has stopped smoking for &gt;6 months prior to visit 2 (preentry) Any clinically significant disease or disorder (eg infections/viral disease, cardiovascular, pulmonary, gastrointestinal, liver, renal, neurological, musculoskeletal, endocrine, metabolic, malignant, psychiatric, major physical impairment), which in the opinion of the investigator, may either put the subject at risk because of participation in the study, or influence the absorption, distribution, metabolism and excretion of drugs. Any clinically relevant abnormal findings in physical examination, vital signs, clinical chemistry, haematology, urinalysis, which, in the opinion of the investigator, may put the subject at risk because of his/her participation in the study Any ECG abnormality (including cardiac arrhythmia) which in the opinion of the investigator may put the subject at risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>COPD</keyword>
</DOC>